PHARMACIE CRUNENBERG-GILLET
0844.540.101 · rovalta.com · 25/09/2026
PHARMACIE CRUNENBERG-GILLET
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMACIE CRUNENBERG-GILLET is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Stavelot. It employs on average 2,1 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0844.540.101
- Incorporation
- 20/03/2012
- Legal form
- Private limited company
- Registered office
- Les Closures 1 box a
4970 Stavelot · WallonieSee on map - Contributed capital
- 75 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 2,1 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 553,7 k € | +6.9% | 518,1 k € | +23.7% | 418,8 k € | +37.1% | 305,6 k € | +18.7% | 257,5 k € |
| EBITDA | 424,7 k € | +9.7% | 387,2 k € | +18.3% | 327,2 k € | +36.2% | 240,2 k € | +18.6% | 202,5 k € |
| Operating result | 271,2 k € | +15.7% | 234,4 k € | +18.0% | 198,7 k € | +33.0% | 149,4 k € | +21.5% | 122,9 k € |
| Net result | 166,8 k € | +19.3% | 139,8 k € | +3.1% | 135,5 k € | +21.1% | 111,9 k € | +14.7% | 97,6 k € |
| Balance sheet | |||||||||
| Equity | 616,1 k € | +11.0% | 554,9 k € | +30.3% | 425,9 k € | +32.2% | 322,1 k € | +28.8% | 250,1 k € |
| Total assets | 2,1 M € | -3.2% | 2,1 M € | -2.2% | 2,2 M € | +17.5% | 1,9 M € | +43.3% | 1,3 M € |
| Cash | 554 k € | +23.7% | 447,7 k € | +83.5% | 244 k € | +7.3% | 227,5 k € | -35.7% | 353,9 k € |
| Debts | 1,4 M € | -7.9% | 1,6 M € | -10.3% | 1,7 M € | +14.3% | 1,5 M € | +46.6% | 1 M € |
| Other | |||||||||
| Workforce | 2,1 ETP | -8.7% | 2,3 ETP | +53.3% | 1,5 ETP | +36.4% | 1,1 ETP | -42.1% | 1,9 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 4 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 24/07/2026 | 28/05/2025 | 26/07/2024 | 03/08/2023 | 14/06/2022 | 29/04/2021 |
| General meeting | 26/06/2026 | 30/04/2025 | 30/06/2024 | 30/06/2023 | 03/06/2022 | 02/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 26/06/2026 | 24/07/2026 | French | |
| Abridged model | 31/12/2024 | 30/04/2025 | 28/05/2025 | French | |
| Abridged model | 31/12/2023 | 30/06/2024 | 26/07/2024 | French | |
| Abridged model | 31/12/2022 | 30/06/2023 | 03/08/2023 | French | |
| Abridged model | 31/12/2021 | 03/06/2022 | 14/06/2022 | French | |
| Abridged model | 31/12/2020 | 02/04/2021 | 29/04/2021 | French | |
| Abridged model | 31/12/2019 | 26/05/2020 | 15/07/2020 | French | |
| Abridged model | 31/12/2018 | 30/06/2019 | 11/07/2019 | French | |
| Abridged model | 31/12/2017 | 22/03/2018 | 18/04/2018 | French | |
| Abridged model | 31/12/2016 | 25/04/2017 | 23/05/2017 | French | |
| Abridged model | 31/12/2015 | 02/05/2016 | 09/05/2016 | French | |
| Abridged model | 31/12/2014 | 21/05/2015 | 29/05/2015 | French | |
| Abridged model | 31/12/2013 | 08/04/2014 | 28/07/2014 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates19/12/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DENOMINATION - OBJET - DEMISSIONS, NOMINATIONS
- Registered office28/11/2022SIEGE SOCIAL - ADRESSE AUTRE QUE SIEGE SOCIAL
- Registered office28/08/2020SIEGE SOCIAL
- Mandates23/12/2015DEMISSIONS, NOMINATIONS
- Other30/03/2012RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025166,8 k €↑
- 2024Annual accounts 2024139,8 k €↑
- 2023Annual accounts 2023135,5 k €↑
- 2023Name changePHARMACIE CRUNENBERG GILLET
- 2022Annual accounts 2022111,9 k €↑
- 2021Annual accounts 202197,6 k €↑
- 2020Annual accounts 202011,3 k €↑
- 2019Annual accounts 2019-12,4 k €↓
- 2018Annual accounts 201813,4 k €↓
- 2017Annual accounts 201733,7 k €↑
- 2016Annual accounts 201627,6 k €↑
- 2015Annual accounts 2015375 €↑
- 2014Annual accounts 2014374,8 €↓
- 2013Annual accounts 201315,9 k €
- 2013Name changePHARMACIE ALINE GILLET
- 20/03/2012IncorporationPrivate limited company